These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prostate cancer screening. Appropriate choices? Investigators of the American Cancer Society National Prostate Cancer Detection Project. Littrup PJ Cancer; 1994 Oct; 74(7 Suppl):2016-22. PubMed ID: 7522122 [TBL] [Abstract][Full Text] [Related]
26. [Knowledge about effectiveness of general screening for prostatic cancer is limited]. Varenhorst E; Carlsson P; Löfman O; Capik E; Pedersen K Lakartidningen; 1992 Nov; 89(45):3835-8. PubMed ID: 1460994 [No Abstract] [Full Text] [Related]
27. Costs and benefits of early detection of prostatic cancer. Carlsson P; Pedersen KV; Varenhorst E Health Policy; 1990 Dec; 16(3):241-53. PubMed ID: 10113546 [TBL] [Abstract][Full Text] [Related]
28. Cost-benefit determinations in screening mammography. Moskowitz M Cancer; 1987 Oct; 60(7 Suppl):1680-3. PubMed ID: 3115556 [TBL] [Abstract][Full Text] [Related]
29. Epidemiology and screening for prostate cancer. Moul JW Am J Manag Care; 1997 Aug; 3(8):1200-5; quiz 1208, 1210. PubMed ID: 10170302 [TBL] [Abstract][Full Text] [Related]
30. Economic considerations in breast cancer screening of older women. Brown ML J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883 [TBL] [Abstract][Full Text] [Related]
31. AUA's response to the OTA study on prostate cancer screening for elderly men. Oncology (Williston Park); 1995 Nov; 9(11):1123. PubMed ID: 8703675 [No Abstract] [Full Text] [Related]
32. Early detection of prostate cancer. Recommendations from the Canadian Urological Association. Ramsey EW Can J Oncol; 1994 Nov; 4 Suppl 1():82-5. PubMed ID: 8853498 [No Abstract] [Full Text] [Related]
33. Strategies to overcome barriers to early detection of cancer among older adults. Rubenstein L Cancer; 1994 Oct; 74(7 Suppl):2190-3. PubMed ID: 8087790 [TBL] [Abstract][Full Text] [Related]
34. [Economic approach to breast cancer screening in Belgium]. Autier P; Grivegnée AR Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252 [TBL] [Abstract][Full Text] [Related]
35. Customizing anticancer strategies to local needs. Webb S J Natl Cancer Inst; 2009 Jun; 101(12):842-4. PubMed ID: 19509362 [No Abstract] [Full Text] [Related]
36. Clinical and economic arguments favour extension to upper age limit for breast screening. Torgerson DJ; Gosden T BMJ; 1998 Jun; 316(7147):1829. PubMed ID: 9624089 [No Abstract] [Full Text] [Related]
37. Screening for breast cancer. O'Doherty AJ; Donaghy P Lancet; 1990 Feb; 335(8684):296. PubMed ID: 1967755 [No Abstract] [Full Text] [Related]
38. Screening for breast cancer. Screening programme not cost effective. Watmough DJ; Kumar K BMJ; 1994 Jan; 308(6922):202. PubMed ID: 8312788 [No Abstract] [Full Text] [Related]
39. Is screening for breast cancer cost-effective? Mushlin AI; Fintor L Cancer; 1992 Apr; 69(7 Suppl):1957-62. PubMed ID: 1544100 [TBL] [Abstract][Full Text] [Related]